AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management [Yahoo! Finance]
AtriCure, Inc. (ATRC)
Last atricure, inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.atricure.com
Company Research
Source: Yahoo! Finance
fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it has launched the cryoSPHERE ® cryoablation probe, leveraging new insulation technology to reduce freeze times by 25% versus AtriCure's legacy cryoSHPERE ® device. The product is currently in an extended limited launch period in the United States, with full launch expected by the end of the second quarter. "cryoSPHERE+ is a meaningful innovation that I believe will improve patient care, enhance outcomes, and enable physicians to perform procedures with greater ease and confidence," said Michael Carrel, President and Chief Executive Officer at AtriCure. "Since the launch of our pain management franchise over five years ago, we've seen a significant impact on patient's lives, and with this launch, we look forward to serving even more people in the future." The cryoSPHERE device, a part of the cryoICE ® platform, is built upon the proven safety and efficacy of the c
Show less
Read more
Impact Snapshot
Event Time:
ATRC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATRC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATRC alerts
High impacting AtriCure, Inc. news events
Weekly update
A roundup of the hottest topics
ATRC
News
- AtriCure to Participate in the 2024 Bank of America Securities Healthcare ConferenceBusiness Wire
- AtriCure upgraded at Oppenheimer on valuation [Seeking Alpha]Seeking Alpha
- AtriCure, Inc. (NASDAQ: ATRC) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $32.00 price target on the stock.MarketBeat
- AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management [Yahoo! Finance]Yahoo! Finance
- AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain ManagementBusiness Wire
ATRC
Earnings
- 2/15/24 - Beat
ATRC
Sec Filings
- 4/23/24 - Form DEFA14A
- 4/23/24 - Form DEFA14A
- 4/3/24 - Form DEFA14A
- ATRC's page on the SEC website